Molecular Pharmacology (USA) Ltd. is a shell company. The company is headquartered in Leederville, Western Australia. The company went IPO on 2005-05-20. The firm is not engaged in any business activities.
Molecular Pharmacology (USA) Ltd 最大收入来源是 Banking and Related Activities,在最近的收益报告中收入为 17,278,000。就地区而言, United States 是 Molecular Pharmacology (USA) Ltd 的主要市场,收入为 17,278,000。